Stable Isotope Labelled Rinucumab Biosimilar – Anti-PDGFRB/ PDGFR-1/CD140b mAb – Research Grade

Reference: PX-TA1400-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Rinucumab Biosimilar - Anti-PDGFRB/ PDGFR-1/CD140b mAb - Research Grade
SourceCAS 1569263-06-4
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsREGN-2176,REGN-2176-3 (combination of aflibercept and ricunumab),REGN2176
ReferencePX-TA1400-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Rinucumab Biosimilar - Anti-PDGFRB/ PDGFR-1/CD140b mAb - Research Grade

General information on Anti-PDGFRB/ PDGFR-1/CD140b[Homo sapiens] (Rinucumab) Monoclonal Antibody

Rinucumab is investigated for the treatment of Neovascular (“Wet”) Age-related Macular Degeneration (AMD).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Rinucumab Biosimilar – Anti-PDGFRB/ PDGFR-1/CD140b mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products